Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Long-term vitamin C supplementation has no markedly favourable effect on serum lipids in middle-aged Japanese subjects
2004
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin
2003
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds
2005
Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
2007
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
2010
Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
2009
Drug Treatment of Hyperlipidemia in Women
2004
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
2009
The role of vitamin E in atherosclerosis
2003
Age-Related Macular Degeneration
2008 Standout
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin
2004
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
2005
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush
2006
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
2007
Mechanism of Action of Niacin
2008
The metabolic syndrome
2010 Standout
Antiatherothrombotic effects of nicotinic acid
2003
High-Density Lipoprotein as a Therapeutic Target
2007
Hallmarks of aging: An expanding universe
2023 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
High-density lipoproteins as therapeutic targets
2005
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin
2003
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials
2003
Statins and C‐Reactive Protein Levels
2007
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial
2003
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)
2007
Design of a novel class of biphenyl CETP inhibitors
2010
Characteristics of US adults with the metabolic syndrome and therapeutic implications
2004
Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production
2004
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease
2008
Myocardial infarction and third generation oral contraceptives: aggregation of recent studies
2002
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Vitamins E and C in the Prevention of Cardiovascular Disease in Men
2008
Combined therapy in the treatment of dyslipidemia
2009
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Update on strategies to increase HDL quantity and function
2009
Beyond High-Density Lipoprotein Cholesterol Levels
2008
Lipoprotein Management in Patients With Cardiometabolic Risk
2008
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid – a position paper developed by the European Consensus Panel on HDL-C*
2004
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
2007
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
2008
Women's Angiographic Vitamin and Estrogen trial:
2002
NAD+ homeostasis in health and disease
2020
Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia
2008
The SU.VI.MAX Study
2004
Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])
2003
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
2012
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
2004 Standout
Niacin therapy in atherosclerosis
2004
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
2005 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
2009
Safety of Aggressive Lipid Management
2007
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Nicotinic Acid-Induced Flushing Is Mediated by Activation of Epidermal Langerhans Cells
2006
New Perspectives on the Use of Niacin in the Treatment of Lipid Disorders
2004
Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
2004
Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?
2005
Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease
2004
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Safety Considerations with Niacin Therapy
2006
Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management
2012
Hepatocellular Carcinoma
2011 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women
2007
Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women
2002
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers
2006
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes
2003
A review of the epidemiological evidence for the ‘antioxidant hypothesis’
2004
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2
2004
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Antioxidant Vitamin Supplements and Cardiovascular Disease
2004
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
The Effect of Vitamin E on Endothelial Function of Micro- and Macrocirculation and Left Ventricular Function in Type 1 and Type 2 Diabetic Patients
2005
Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins
2007
Clinical trials report
2002
Engineering the defect state and reducibility of ceria based nanoparticles for improved anti-oxidation performance
2015
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer
2005
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations 1–3
2006
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression
2003
Niacin therapy in atherosclerosis
2005
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
Change in α 1 HDL Concentration Predicts Progression in Coronary Artery Stenosis
2003
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Low HDL Cholesterol Levels
2005
Ascorbic Acid Reduces Blood Pressure and Arterial Stiffness in Type 2 Diabetes
2002
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004
Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?
2002
Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes
2002
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
High-Density Lipoprotein Cholesterol and the Role of Statins.
2002
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Essential Nutrients: Food or Supplements?
2005
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers
2006
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis
2002
Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans
2004
Works of Bryan Brown being referenced
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
2001